Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Ovarian Neoplasms 7 Glioblastoma 4 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Neoplasms 2 Head and Neck Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Rare Tumour 1 Neuroectodermal Tumors 1 Nervous System Diseases 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoadjuvant Therapy 1 Metastatic Castration-resistant Prostate Cancer 1 Metastatic Castration-Resistant Prostate Cancer (mCRPC) 1 Locally Advanced Prostate Cancer 1 Limited Stage Small Cell Lung Cancer 1 Hereditary leiomyomatosis and renal cell cancer 1 HER2-negative Breast Cancer 1 Gliosarcoma 1 Glioma 1 For Participants With Advanced Solid Tumors Failed With Previous Lines of Treatment 1 Esophageal Neoplasms 1 Central Nervous System Neoplasms 1 Carcinosarcoma 1

Interventions

Gemcitabine 92 Cisplatin 70 Oxaliplatin 37 Capecitabine 37 durvalumab 29 Fluorouracil 26 pembrolizumab 24 Leucovorin 22 S 1 (combination) 18 Nivolumab 13 Irinotecan 13 Bevacizumab 13 lenvatinib 12 tremelimumab 10 apatinib 8 Trastuzumab 7 Injections 7 Albumin-Bound Paclitaxel 7 130-nm albumin-bound paclitaxel 7 Paclitaxel 6 Immune Checkpoint Inhibitors 6 Docetaxel 6 titanium silicide 5 surufatinib 5 envafolimab 5 camrelizumab 5 atezolizumab 5 Folfox protocol 5 Drug Therapy 5 Carboplatin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Biliary Tract Neoplasms × pamiparib × Clear all

NCT04796454 2022-06-01

PAMICC

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Withdrawn

Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡